This
page
is
part
of
the
FHIR
Specification
(v4.0.1:
R4
-
Mixed
Normative
and
STU
)
in
it's
permanent
home
(it
will
always
be
available
at
this
URL).
(v4.2.0:
R5
Preview
#1).
The
current
version
which
supercedes
this
version
is
5.0.0
.
For
a
full
list
of
available
versions,
see
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
R3
R2
RXD-20-Substance
Manufacturer
Name
/
RXG-21-Substance
Manufacturer
Name
/
RXA-17-Substance
Manufacturer
Name
form
doseForm
RXO-5-Requested
Dosage
Form
/
RXE-6-Give
Dosage
Form
/
RXD-6-Actual
Dosage
Form
/
RXG-8-Give
Dosage
Form
/
RXA-8-Administered
Dosage
Form
amount
ingredient
item[x]
RXC-2-Component
Code
if
medication:
RXO-1-Requested
Give
Code
/
RXE-2-Give
Code
/
RXD-2-Dispense/Give
Code
/
RXG-4-Give
Code
/
RXA-5-Administered
Code
isActive
strength
strength[x]
RXC-3-Component
Amount
&
RXC-4-Component
Units
if
medication:
RXO-2-Requested
Give
Amount
-
Minimum
&
RXO-4-Requested
Give
Units
/
RXO-3-Requested
Give
Amount
-
Maximum
&
RXO-4-Requested
Give
Units
/
RXO-11-Requested
Dispense
Amount
&
RXO-12-Requested
Dispense
Units
/
RXE-3-Give
Amount
-
Minimum
&
RXE-5-Give
Units
/
RXE-4-Give
Amount
-
Maximum
&
RXE-5-Give
Units
/
RXE-10-Dispense
Amount
&
RXE-10-Dispense
Units
batch
lotNumber
RXA-15
Substance
Lot
Number
/
RXG-19
Substance
Lot
Number
expirationDate
RXA-16
Substance
Expiration
Date
/
RXG-20
Substance
Expiration
Date